TCL Archive The Raghavan Experiment: With $500 Million to Draw On, An Iconoclast Invents Rational Care for a Gigantic System By Cancer History Project January 4, 2013
TCL Archive Sequestration Delayed For Two Months While Congress Debates Debt and Budgets By Cancer History Project January 4, 2013
TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response By Cancer History Project December 28, 2012
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease By Cancer History Project December 28, 2012
TCL Archive Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival By Cancer History Project December 28, 2012
TCL Archive Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients By Cancer History Project December 28, 2012
TCL Archive Breast Cancer Risk Increases With Repeated CT Imaging By Cancer History Project December 28, 2012
Article Elaine Nord, photographer and neuroendocrine cancer survivor, speaks at the 2024 NETRF Symposium By NETRF
Article Ramesh Shivdasani: Viewing Intestinal NETs Through the Lens of Normal Human Enteroendocrine Cell Differentiation By NETRF
